Proactive Research analyst Ed Stacey takes a closer look at Psyched Wellness Ltd (CSE: PSYC) (OTCQB: PSYCF), a health supplements company developing a unique range of products which harness the properties of a specific type of mushroom.
The functional mushrooms market is a large and growing segment in consumer health, currently running at around US$30bn per year globally.
Within the sector, many companies are looking at ways to work with psychedelic mushrooms, which are believed to offer physical and mental health benefits when consumed at low doses.